Rennova Health, Inc. (RNVA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST

Rennova Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-7.73-3.295.61-18.34-48.03
Depreciation & Amortization
0.310.470.640.70.8
Other Amortization
---0.1216.22
Loss (Gain) From Sale of Assets
-00.270.01-
Asset Writedown & Restructuring Costs
--2.30.25-
Loss (Gain) From Sale of Investments
0.82----
Stock-Based Compensation
-----0.05
Other Operating Activities
7.35-1.02-22.29-9.498.11
Change in Accounts Receivable
0.02-0.34-0.541.45-1
Change in Inventory
0.040.040.160.170.16
Change in Accounts Payable
1.17-0.010.091.46.23
Change in Other Net Operating Assets
1.23.624.567.623.54
Operating Cash Flow
3.39-0.22-8.91-16.93-13.53
Capital Expenditures
-0.35-0.04--0.37-0
Sale of Property, Plant & Equipment
---0.08-
Cash Acquisitions
-----0.66
Other Investing Activities
-1.18-0.87-0.37--
Investing Cash Flow
-1.53-0.91-0.37-0.29-0.66
Short-Term Debt Issued
0.581.050.897.6316.67
Long-Term Debt Issued
-0.51.253.465.45
Total Debt Issued
0.581.552.1411.0922.11
Short-Term Debt Repaid
-1.41-0.18-0.86-4.19-2.31
Long-Term Debt Repaid
-1.48-1.57-0.75-2.71-5.2
Total Debt Repaid
-2.89-1.75-1.61-6.9-7.51
Net Debt Issued (Repaid)
-2.31-0.20.524.1914.6
Repurchase of Common Stock
--0-0-0-
Other Financing Activities
--0.40.4613.03-0.4
Financing Cash Flow
-2.310.99.9917.2314.2
Net Cash Flow
-0.45-0.230.70.010.01
Free Cash Flow
3.04-0.25-8.91-17.3-13.53
Free Cash Flow Margin
16.25%-1.94%-276.46%-240.26%-84.54%
Free Cash Flow Per Share
---16.25--
Cash Interest Paid
0.421.550.10.06-
Cash Income Tax Paid
--0.28-0.05
Levered Free Cash Flow
3.44-0.05-17.34-7.743.75
Unlevered Free Cash Flow
4.351.36-15.34-1.711.11
Change in Working Capital
2.683.624.449.938.89
Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.